Drugs / Near Infrared Imaging
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01808417 | Jun 2013 → Apr 2014 | esophageal cancer | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Near Infrared Imaging | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01808417 ↗ |
| Modality | Diagnostic / imaging agent | “ICG can be detected within the body using special near-infrared light cameras.” NCT01808417 ↗ |
| Route | Other | “administered in four small injections immediately around your tumor” NCT01808417 ↗ |